Navigation Links
Researchers discover Achilles' heel in lethal form of prostate cancer
Date:11/16/2011

NEW YORK -- An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers.

In today's issue of Cancer Discovery, the researchers report that the investigational drug had a dramatic response in animal models of neuroendocrine prostate cancer, and so provides the first hope of an effective human therapy for this lethal cancer. While fewer than 2 percent of prostate tumors in men are initially classified as neuroendocrine, many common adenocarcinoma prostate cancers change their biology during hormone therapy and morph into this aggressive subtype.

The study is the largest in-depth analysis of neuroendocrine prostate cancer yet undertaken, and the findings "are very exciting, because our bench-to-bedside approach identified a new molecular target for a subtype of prostate cancer for which a drug is now available," says the study's senior investigator, Dr. Mark A. Rubin, a professor of pathology and laboratory medicine at Weill Cornell Medical College and a pathologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

The finding is especially important because many men are now being treated with new, highly potent androgen suppression therapy, which these researchers believe will significantly increase the risk of future development of neuroendocrine tumors. Androgen is the fuel that feeds adenocarcinoma prostate cancers -- the most common kind of prostate cancer -- and androgen suppression therapy effectively destroys cancer cells that depend on this hormone. But the treatment does not touch neuroendocrine cells that may have been part of the tumor mix, and those untreatable cells now have room to grow and spread, the researchers say.

Although most of the approximately 30,0
'/>"/>

Contact: John Rodgers
jdr2001@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Jackson Laboratory researchers uncover steps in synapse building, pruning
2. UCLA stem cell researchers uncover mechanism that regulates human pluripotent stem cell metabolism
3. Ben-Gurion University of the Negev researchers achieve male fertility breakthrough
4. Canadian researchers find potential new leukemia treatment with old antibiotic drug
5. FDA funds Rochester researchers to give chronic and acute pain clinical trials a makeover
6. Jefferson researchers study outcomes of carotid artery stenting following prior carotid procedure
7. Researchers gain insight into 100-year-old Haber-Bbosch process
8. New funding will help researchers learn how preschoolers move, battle early child obesity
9. Pitt researchers using mathematics to target Parkinsons disease symptoms
10. Moffitt Cancer Center researchers unravel biochemical factor important in tumor metastasis
11. Lose the fat and improve the gums, CWRU dental researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Mirada, CA (PRWEB) March 28, 2015 ... ear, nose and throat disorders, are now ... is a common issue which is characterized by the ... Affecting 1 in 5 people, tinnitus is a prevalent ... disorder and while it is non-fatal, tinnitus can impede ...
(Date:3/28/2015)... March 28, 2015 ARDX will sponsor the ... 12pm -3pm at the Chesapeake Conference Center in Chesapeake, Virginia. ... an empowering event for women in the Hampton Roads region. ... Stories of Women’s Lives. Women grow stronger through sharing ... other. This year the WWC™ theme is T-talk where ...
(Date:3/28/2015)... LTW Cyber is an innovation hub for ... purpose of addressing the needs of the global market ... opportunities to grow while seeking collaborative opportunities with the ... Ventures in LTW Cyber focus on secure application security, ... vulnerabilities and analyzing open source. As the hub ...
(Date:3/27/2015)... Deer, Alberta (PRWEB) March 27, 2015 In ... until then, prevented her from working, Monica K. arrived at ... in the mending department quiet, defensive and scared. The owners ... Placement & Support Services (EPSS) to offer jobs to ... does take patience and a willingness to begin with the ...
(Date:3/27/2015)... Lewisville, Texas (PRWEB) March 27, 2015 ... at 7am today. The new facility is located 12665 W ... , “As a resident of Summerwood, I look forward to ... here,” said Dr. Sowell, Facility Medical Director of First Choice ... First Choice Emergency Room made a donation to Summer Creek ...
Breaking Medicine News(10 mins):Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2
... of Dimes and Kmart--Working Together for Stronger, Healthier,Babies, ... premature birth rises in the U.S., Kmart,s partnership with ... Kmart,s associates and customers,have raised an unprecedented $71 million ... This year, Kmart,s 2008 March for Babies,campaign topped the ...
... Efforts Oppose $6.5 Million Funding Cut to State,s ... The Arkansas,Health Care Association and the American Health ... and Mark Pryor (D) and,Representatives Marion Berry (D-1st), ... (D-4th) for helping lead efforts in the U.S. ...
... the 1 in 8 Hispanics with type 2 disease , , ... of the most serious health issues facing Hispanics in the ... diabetes has been released. , The Agency for Healthcare Research ... 2 , a consumer guide aimed at the estimated one ...
... From Various Pro Teams During Each Tour ... Stage, LAKE SUCCESS, N.Y., July 2 , WHO: ... assessment technology, WHAT: Micro-site ... various pro cyclists during every stage of the Tour de France. ...
... Inc., the,highly respected developer and manufacturer of proprietary ... Stable Liquid L-Ascorbic Acid,(Vitamin C), has terminated the ... right to exclusively market the proprietary,product formulas of ... IS Clinical termination was triggered by that company,s,introduction ...
... rises in caesarean section rates, according to a paper ... The findings come from an analysis of a large ... Professor Gordon Smith, at the University,s Department of Obstetrics ... 500,000 entries collected by the Scottish Morbidity Record between ...
Cached Medicine News:Health News:4 Million Babies Born Each Year in United States; $8 Million That Shows You Care About All of Them! 2Health News:State, National Long Term Care Community Applauds Arkansas Leaders in U.S. Senate and U.S. House for Helping Lead Effort to Block $770 Million Bush Medicare Cuts 2Health News:State, National Long Term Care Community Applauds Arkansas Leaders in U.S. Senate and U.S. House for Helping Lead Effort to Block $770 Million Bush Medicare Cuts 3Health News:New Spanish Consumer Guide Compares Diabetes Meds 2Health News:Polar to Feature Live Tour de France Race Data 2Health News:Termination of IS Clinical From Distributing PhytoCeuticals Formulas 2Health News:Major rise in Caesarean sections linked to impaired womb function with age 2
(Date:3/27/2015)... 2015 /CNW Telbec/ - Russell Williams , President ... (Rx&D), welcomes the 2015-2016 Quebec Budget, noting the fiscal ... the biopharmaceutical industry. However, the association is concerned about ... commend the government,s intent to strive for a balanced ... promote Quebec,s economic development is ...
(Date:3/27/2015)... Biopharmaceutical Industry Leads Manufacturing Sector in ... on top as the country,s manufacturing leader in innovation ... ndp│analytics. According to the  analysis , the industry had ... last decade, accounting for 27 percent of average annual ... Short Video on Medicare Part D - Medicare ...
(Date:3/27/2015)... The Temple Health & Bioscience District (THBD) today announced it ... South First St. in the Temple Medical and Education District ... of Temple to receive funding for redevelopment. Located ... Health Care System, the new facility will enable THBD to ... life science companies. Temple ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Week in Review: The Latest from PhRMA 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2
... of Sexual Medicine INDIANAPOLIS, May 6 Eli Lilly ... results from a double-blind, placebo-controlled study which showed that ... well-tolerated, improved erectile function for men with erectile dysfunction ... life scores for men and their female partners. The ...
... 6 D-Pharm announced today that it,has submitted IND ... and Drug Administration (FDA), for its pivotal Phase III ... plans to initiate the,trial later this year following FDA ... Scientific Advice from the European Medicines Agency,(EMEA) on the ...
Cached Medicine Technology:Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 2Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 3Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 4Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples 5D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 2D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: